Clinical trial to evaluate the safety and efficacy of OBI-992 in advanced solid tumors.
TAIPEI, Taiwan, June 12, 2024 (GLOBE NEWSWIRE) - OBI Pharma, a clinical-stage oncology company (4174.TWO), toda...
Copenhagen Infrastructure Partners (CIP), through its CI Advanced Bioenergy Fund I (CI ABF I), today announced the launch of Greengate Biogas in partnership with Atlas Renewables and Energex Partners....